Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT00509431 · COMPLETED

Trial details

NCT number: NCT00509431
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2006-08-01
Primary completion: 2011-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.